Risk assessment of asthma and allergic rhinitis in atopic dermatitis patients treated with biologics and JAK inhibitors: a systematic review and network meta-analysis of randomized controlled trials.

Cibinqo (abrocitinib) - Pfizer

Adbry (tralokinumab-ldrm) - LEO Pharma, AstraZeneca

Nemluvio (nemolizumab-ilto) - Galderma

Dupixent (dupilumab) - Sanofi, Regeneron

telazorlimab (ISB 830) - Astria Therap

http://www.ncbi.nlm.nih.gov/pubmed/41652607

Hualian Luo; Jing Li; Jing Liu; Liling Zeng; Lishan Zhang; Mo Xian; Shiyan Fu; Tong Zhou; Zheng Zhu

Feb 7, 2026